semaglutide from compounding pharmacy API sourcing for compounded drugs Thinking of using a compounding

38 , 39 , 40 There are no clinical data on the simultaneous effect of GIP, GLP1, and glucagon receptor agonism on appetite and eating constructs

That is a signal worth serious attention as TRIUMPH-1, TRIUMPH-2 and TRIUMPH-3 mature through 2026 and 2027

Why so much higher

As a triple agonist with superior weight loss data, it may command a premium over existing dual agonists

Recent articles Nutrition Weight Management For Employers Beyond weight loss: the expanding research on GLP-1s 6/25/2026 For Employers GLP-1 trends employers should know in 2026 4/21/2026 Featured Medications Weight Management New weight loss pills: what the latest FDA approvals mean 4/15/2026 Get the latest tips to your inbox

CagriSema vs Retatrutide is one of the most important next-generation obesity peptide comparisons going into 2026